RESPIRATORY CONDITION 1

To reduce the cough reflex.

Yes, people with asthma may be at increased risk.

Variable airflow limitation in response to allergenic triggers.

It commonly follows a cold or viral infection.

It is a scoring system used to assess the severity of pneumonia in patients.

Chest radiography with lung infiltration.

Getting a yearly flu vaccine.

Coughing.

It is used for patients on high-dose ICS + LABA who are symptomatic with frequent exacerbations and have allergies as an important cause of asthma.

A persistent, mucus-producing cough on most days of the month for 3 months of a year for 2 successive years, in absence of a secondary cause.

Confusion, Respiratory rate, Blood pressure, Age 65 or older.

To deliver medication directly to the lungs to relieve asthma symptoms.

Acute bacterial exacerbation of chronic bronchitis.

MDI, Turbohaler®, Accuhaler®, Easyhaler®.

Lung abnormalities such as pneumonia or other complications.

Avoiding tobacco smoke and exposure to secondhand smoke.

History taking, physical examination, chest x-rays, sputum cultures, pulmonary function tests, spirometer exercises, and bronchoscopy.

Inflammation or swelling of the bronchial tubes (bronchi), the air passages between the nose and the lungs.

Chest X-ray.

It reduces the thickness or viscosity of bronchial secretions, making mucus flow easier and facilitating its removal.

Suppress inflammatory cell activity to prevent/control inflammation.

A chronic respiratory condition characterized by airway inflammation and constriction.

Shortness of breath and wheezing.

Inflammation of the lung parenchyma caused by microorganisms.

Patients who have difficulty coordinating inhalation with MDI use, such as children or those with severe asthma.

NSAIDs and Beta-blockers.

Allergens, smoke, pollution, exercise, and respiratory infections.

A chronic airway inflammatory disorder.

Bacterial infection leading to an exacerbation of chronic bronchitis.

5 variables used to assess the severity of pneumonia.

Bronchodilators dilate the bronchial tubes and help clear out mucus, reducing wheezing.

Pneumococcal vaccine.

Allergens (like house dust mites and pollen), environmental exposure (like cigarette smoke), medications (like beta-blockers), and certain foods (like nuts and dairy).

To help patients manage their Asthma and COPD.

Antibiotics are effective for bacterial infections, but not for viral infections.

To improve asthma care and reduce the burden of asthma globally.

It may detect pneumonia in patients without obvious signs or identify hypoxemia in diagnosed pneumonia patients.

Shake the inhaler well before use to ensure the medication is mixed properly.

Anti-inflammatory medicines and glucocorticoid steroids.

Global Initiative for Asthma.

It inhibits IgE binding to IgE receptors on mast cells and basophils, reducing mediator release in allergic responses.

It breaks down the chemical structure of mucus molecules, thinning the mucus for easier removal through coughing.

Family history of asthma, family history of atopic diseases, obesity, and gender.

Viruses, bacteria, and other particles that irritate the bronchial tubes.

Medication history, understanding of the disease and medications, compliance, inhaler technique, and relevant findings.

Tobacco smoke exposure.

Majority of the conditions are self-limiting or minor.

Inhaler skills, self-monitoring, and adherence to treatment.

A scoring system that uses 20 variables to assess pneumonia severity.

Acts on β2 receptors to produce relaxation of bronchial smooth muscle (bronchodilation).

S. pneumoniae, H. influenzae, and M. pneumoniae.

Treating modifiable risk factors, managing comorbidities, and using non-pharmacological therapies.

To encourage deep breathing and improve lung function.

Yes, it is considered safe.

Individuals over 50 years old, household contacts of high-risk persons, and healthcare workers.

They act as pathways for air and food.